Johnson & Johnson (J&J), the world's biggest healthcare company, has invested $1.5 billion in Irish biopharmaceutical company Elan Corporation. New Brunswick, New Jersey-based J&J will take over ElanÔÇÖs 50 percent stake in its Alzheimer's immunotherapy research partnership, or AIP Program, that it currently runs with Madison, New Jersey-based pharmaceutical firm Wyeth.

